155 related articles for article (PubMed ID: 18384628)
21. Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
Poincloux L; Durando X; Seitz JF; Thivat E; Bardou VJ; Giovannini MH; Parriaux D; Barriere N; Giovannini M; Delpero JR; Monges G
Surg Oncol; 2009 Dec; 18(4):357-65. PubMed ID: 19027288
[TBL] [Abstract][Full Text] [Related]
22. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
[TBL] [Abstract][Full Text] [Related]
23. Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma.
Rouprêt M; Cancel-Tassin G; Comperat E; Fromont G; Sibony M; Molinié V; Allory Y; Triau S; Champigneulle J; Gaffory C; Larré S; de la Taille A; Richard F; Hamdy FC; Cussenot O
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2500-3. PubMed ID: 18006944
[TBL] [Abstract][Full Text] [Related]
24. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
Gupta R; Paner GP; Amin MB
Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
[TBL] [Abstract][Full Text] [Related]
25. [Primary upper urinary tract tumors and subsequent location in the bladder].
Azémar MD; Audouin M; Revaux A; Misraï V; Comperat E; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Rouprêt M
Prog Urol; 2009 Oct; 19(9):583-8. PubMed ID: 19800544
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of cyclooxygenase-2 in urothelial carcinoma in conjunction with tumor-associated-macrophage infiltration, hypoxia-inducible factor-1alpha expression, and tumor angiogenesis.
Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH; Chai CY
APMIS; 2009 Mar; 117(3):176-84. PubMed ID: 19245590
[TBL] [Abstract][Full Text] [Related]
27. Large-scale analysis of cell cycle regulators in urothelial bladder cancer identifies p16 and p27 as potentially useful prognostic markers.
Brunner A; Verdorfer I; Prelog M; Mayerl C; Mikuz G; Tzankov A
Pathobiology; 2008; 75(1):25-33. PubMed ID: 18334837
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract.
Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E
Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504
[TBL] [Abstract][Full Text] [Related]
29. Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappaB is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure.
Konda R; Sugimura J; Sohma F; Katagiri T; Nakamura Y; Fujioka T
J Urol; 2008 Aug; 180(2):481-5. PubMed ID: 18550099
[TBL] [Abstract][Full Text] [Related]
30. The molecular signature for urothelial carcinoma of the upper urinary tract.
Ho CL; Tzai TS; Chen JC; Tsai HW; Cheng HL; Eisenberger CF; Chow NH
J Urol; 2008 Mar; 179(3):1155-9. PubMed ID: 18206169
[TBL] [Abstract][Full Text] [Related]
31. L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
J Surg Oncol; 2009 Jun; 99(7):433-8. PubMed ID: 19347882
[TBL] [Abstract][Full Text] [Related]
32. Molecular aspects of upper tract urothelial carcinoma.
Patel N; Arya M; Muneer A; Powles T; Sullivan M; Hines J; Kelly J
Urol Oncol; 2014 Jan; 32(1):28.e11-20. PubMed ID: 23428541
[TBL] [Abstract][Full Text] [Related]
33. Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization.
Wang X; MacLennan GT; Zhang S; Montironi R; Lopez-Beltran A; Tan PH; Foster S; Baldridge LA; Cheng L
Hum Pathol; 2009 Feb; 40(2):211-7. PubMed ID: 18799188
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
[TBL] [Abstract][Full Text] [Related]
35. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer.
Kim WB; Han HJ; Lee HJ; Park SS; Song TJ; Kim HK; Suh SO; Kim YC; Choi SY
Ann Surg Oncol; 2009 Jan; 16(1):23-34. PubMed ID: 18979138
[TBL] [Abstract][Full Text] [Related]
36. Glucose-regulated protein 78 expression in urothelial carcinoma of the upper urinary tract.
Uematsu K; Ogata S; Nakanishi K; Hiroi S; Tominaga S; Aida S; Kawai T
BJU Int; 2010 Sep; 106(6):873-8. PubMed ID: 20039870
[TBL] [Abstract][Full Text] [Related]
37. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.
Ferreira AM; Westers H; Sousa S; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; Reuvekamp PT; Seruca R; Kleibeuker JH; Hollema H; Sijmons RH; Hofstra RM
J Pathol; 2009 Sep; 219(1):96-102. PubMed ID: 19521971
[TBL] [Abstract][Full Text] [Related]
38. The importance of determining the aggressiveness of prostate cancer using serum and tissue molecular markers.
Kehinde EO; Maghrebi MA; Anim JT
Can J Urol; 2008 Apr; 15(2):3967-74. PubMed ID: 18405443
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]